Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer

Eur Urol. 2022 Feb;81(2):219-221. doi: 10.1016/j.eururo.2021.10.015. Epub 2021 Nov 7.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors
  • Magnetic Resonance Imaging / methods
  • Male
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / metabolism
  • Pyruvic Acid*
  • Radioimmunotherapy

Substances

  • Immune Checkpoint Inhibitors
  • Pyruvic Acid